<--- Back to Details
First PageDocument Content
Pharmaceutics / Clinical research / Pharmacy / Bioequivalence / Pharmaceutical industry / Pharmacovigilance / Clinical trial / Cmax / Bioavailability / Pharmaceutical sciences / Pharmacology / Pharmacokinetics
Date: 2014-10-10 05:28:26
Pharmaceutics
Clinical research
Pharmacy
Bioequivalence
Pharmaceutical industry
Pharmacovigilance
Clinical trial
Cmax
Bioavailability
Pharmaceutical sciences
Pharmacology
Pharmacokinetics

Doc. Ref: CMDhRev.4 September 2014

Add to Reading List

Source URL: www.hma.eu

Download Document from Source Website

File Size: 123,50 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvyp - View Document

conferenceseries.com 1575th Conference March 2018 | Volume 7 ISSN: Journal of Pharmaceutics & Drug Delivery Research

DocID: 1vclS - View Document

医療薬学実習(薬剤、大河原賢一), Clinical Pharmacy (Pharmaceutics-2) 項目 A B

DocID: 1uNpr - View Document

ORIGINAL ARTICLE Clinical Implications of Molecular PEGylation on Therapeutic Proteins Nandhakumar Sathyamoorthy, Dhanaraju Dasaratha Magharla Department of Pharmaceutics, GIET School of Pharmacy, Rajahmundry, Andhra Pr

DocID: 1uHNe - View Document

Int. J. Manag. Bus. Res., 6 (1), 23-34, Winter 2016 © IAU Ranking Pharmaceutics Industry Using SD-Heuristics Approach 1*

DocID: 1uqmz - View Document